HIRSCHMAN ORIN 13D/13G Filings for Plus Therapeutics, Inc. (PSTV)

HIRSCHMAN ORIN 13D and 13G filings for Plus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-10
08:27 am
Sale		 2024-12-31 13G Plus Therapeutics, Inc.
PSTV		 HIRSCHMAN ORIN 560,905
9.500%		 -7,776decrease
(-1.37%)		 Filing
2024-06-05
07:26 am
Purchase		 2024-05-09 13G Plus Therapeutics, Inc.
PSTV		 HIRSCHMAN ORIN 568,681
9.900%		 568,681increase
(New Position)		 Filing